The obtained results of this clinical trial indicated that melatonin supplementation for 10 weeks did not improve markers of inflammation and oxidative stress including hs-CRP, IL-6, TOS, TAS, and MDA in diabetic patients with CKD. Here, IL6 is linked to chronic kidney disease.